This contract expires in 191 days (Dec 19, 2026).

Browse related active opportunities

FIRM FIXED PRICE

ADVANCED ACCELERATOR APPLICATIONS USA INC - VISN PADIOPHARMACEUTICAL PLUVICTO DRUG

PIID: 36C24926N0263
Signed Date: Dec 16, 2025Effective Date: Dec 20, 2025End Date: Closes in 191 days
Award $
$2.4M
Vendor
ADVANCED ACCELERATOR APPLICATIONS USA INC
NAICS
325412
Signed Date
Dec 16, 2025

Key Details

Dollars Obligated
$2.4M
Base & All Options
$2.4M
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
EAST HANOVER, NJ, 079361416, CD-NJ-11

Description

VISN PADIOPHARMACEUTICAL PLUVICTO DRUG

Context & Analysis

On Dec 16, 2025, Department of Veterans Affairs obligated $2,366,303.94 to ADVANCED ACCELERATOR APPLICATIONS USA INC for visn padiopharmaceutical pluvicto drug. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in EAST HANOVER, NJ. The contract is scheduled through Dec 19, 2026 — approximately 6 months remaining.

Contractor Information

UEI: JNM4NBNHFE66
CAGE Code: 3PTH3
Location: NEW YORK, NY
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related